Related Experiment Videos
Prokaryotic expression of antibodies
Mehdi Arbabi-Ghahroudi1, Jamshid Tanha, Roger MacKenzie
1Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ontario. roger.mackenzie@nrc-cnrc.gc.ca
Cancer Metastasis Reviews
|January 13, 2006
Summary
Maximizing antibody expression in Escherichia coli (E. coli) is key for reducing costs. This review focuses on improving yields for antibody fragments, especially single-domain antibodies, using E. coli expression systems.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- High-level expression of recombinant antibodies and fragments is crucial for cost-effective biomanufacturing.
- Escherichia coli (E. coli) is a popular prokaryotic system for expressing antibody fragments due to its cost-effectiveness and convenience.
- Suboptimal yields are frequently encountered, necessitating investigation into factors affecting antibody production.
Purpose of the Study:
- To review various aspects of antibody expression in E. coli.
- To highlight strategies for maximizing expression yields of antibody fragments.
- To focus specifically on optimizing single-domain antibody production in E. coli.
Main Methods:
- Review of existing literature on antibody expression systems.
- Analysis of factors influencing recombinant protein production in E. coli.
- Focus on optimization techniques for antibody fragments, particularly single-domain antibodies.
Main Results:
- E. coli offers advantages for expressing antibody fragments like Fabs, single-chain Fvs, and single-domain antibodies.
- Various intrinsic and extrinsic variables impact expression yields.
- Strategies exist to enhance antibody fragment production in E. coli.
Conclusions:
- Optimizing E. coli expression systems is vital for efficient production of recombinant antibodies and fragments.
- Further research into yield-enhancing variables can lower production costs.
- Single-domain antibodies represent a key area for E. coli-based expression optimization.